Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cressey

Showing results (51-60 of 160) with videos related to

Pageof 16
Sort By:
Pharmacology Research & Perspectives|November 7, 2024
Favipiravir pharmacokinetics in Thai adults with mild COVID-19: A sub-study of interpatient variability and ethnic differences in exposureIng-Orn Prasanchaimontri, Weerawat Manosuthi, Henry Pertinez, et al.
The Pediatric Infectious Disease Journal|April 15, 2025
Pharmacokinetics of Generic Pediatric Abacavir/Lamivudine Dispersible Tablets in Thai Young Children Living With HIV Weighing Below Twenty KilogramsNoppadol Wacharachaisurapol, Athiporn Rungsapphaiboon, Suvaporn Anugulruengkitt, et al.
The Pediatric Infectious Disease Journal|November 1, 2017
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing GuidelinesJorge A Pinto, Edmund V Capparelli, Meredith Warshaw, et al.
The Pediatric Infectious Disease Journal|January 21, 2025
Pharmacokinetics of Generic Pediatric Abacavir/Lamivudine Dispersible Tablets in Thai Young Children Living With HIV Weighing Below Twenty KilogramsNoppadol Wacharachaisurapol, Athiporn Rungsapphaiboon, Suvaporn Anugulruengkitt, et al.
Open Forum Infectious Diseases|August 25, 2022
Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence MonitoringXin Niu, Rachel W Kubiak, Oraphan Siriprakaisil, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2024
Population pharmacokinetics of ravidasvir in adults with chronic hepatitis C virus infection and impact of antiretroviral treatmentNavarat Panjasawatwong, Anchalee Avihingsanon, Caroline Menétrey, et al.
AIDS Care|December 5, 2025
Maternal and health worker preferences for paediatric antiretroviral formulations in neonates exposed to HIVCharlene Purdy, Verah Luke, Samantha du Toit, et al.
Plos One|February 22, 2024
A pilot program of HIV pre-exposure prophylaxis in Thai youthSupattra Rungmaitree, Peerawong Werarak, Wadchara Pumpradit, et al.
Journal of the International AIDS Society|June 19, 2026
Acceptability of a Dolutegravir Oral Dispersible Film in Term Neonates Born to Mothers Living With HIVLario Viljoen, Charlene Purdy, Verah Luke, et al.
The Pediatric Infectious Disease Journal|September 12, 2018
Nevirapine Concentrations During the First Month of Life and Maternal Efavirenz Washout in High-Risk HIV-Exposed Infants Receiving Triple Antiretroviral ProphylaxisSuvaporn Anugulruengkitt, Tim R Cressey, Piyarat Suntarattiwong, et al.
Pageof 16

Showing results (51-60 of 160) with videos related to

Sort By:
Pageof 16
Pharmacology Research & Perspectives|November 7, 2024
Favipiravir pharmacokinetics in Thai adults with mild COVID-19: A sub-study of interpatient variability and ethnic differences in exposureIng-Orn Prasanchaimontri, Weerawat Manosuthi, Henry Pertinez, et al.
The Pediatric Infectious Disease Journal|April 15, 2025
Pharmacokinetics of Generic Pediatric Abacavir/Lamivudine Dispersible Tablets in Thai Young Children Living With HIV Weighing Below Twenty KilogramsNoppadol Wacharachaisurapol, Athiporn Rungsapphaiboon, Suvaporn Anugulruengkitt, et al.
The Pediatric Infectious Disease Journal|November 1, 2017
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing GuidelinesJorge A Pinto, Edmund V Capparelli, Meredith Warshaw, et al.
The Pediatric Infectious Disease Journal|January 21, 2025
Pharmacokinetics of Generic Pediatric Abacavir/Lamivudine Dispersible Tablets in Thai Young Children Living With HIV Weighing Below Twenty KilogramsNoppadol Wacharachaisurapol, Athiporn Rungsapphaiboon, Suvaporn Anugulruengkitt, et al.
Open Forum Infectious Diseases|August 25, 2022
Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence MonitoringXin Niu, Rachel W Kubiak, Oraphan Siriprakaisil, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2024
Population pharmacokinetics of ravidasvir in adults with chronic hepatitis C virus infection and impact of antiretroviral treatmentNavarat Panjasawatwong, Anchalee Avihingsanon, Caroline Menétrey, et al.
AIDS Care|December 5, 2025
Maternal and health worker preferences for paediatric antiretroviral formulations in neonates exposed to HIVCharlene Purdy, Verah Luke, Samantha du Toit, et al.
Plos One|February 22, 2024
A pilot program of HIV pre-exposure prophylaxis in Thai youthSupattra Rungmaitree, Peerawong Werarak, Wadchara Pumpradit, et al.
Journal of the International AIDS Society|June 19, 2026
Acceptability of a Dolutegravir Oral Dispersible Film in Term Neonates Born to Mothers Living With HIVLario Viljoen, Charlene Purdy, Verah Luke, et al.
The Pediatric Infectious Disease Journal|September 12, 2018
Nevirapine Concentrations During the First Month of Life and Maternal Efavirenz Washout in High-Risk HIV-Exposed Infants Receiving Triple Antiretroviral ProphylaxisSuvaporn Anugulruengkitt, Tim R Cressey, Piyarat Suntarattiwong, et al.
Pageof 16